To cite this paper use one of the standards below:
Introduction: Ventilator-associated pneumonia (VAP) is one of the main infections present in intensive care units (ICUs) worldwide, accounting for approximately 80% of cases of nosocomial pneumonia. In this context, the current COVID-19 disease pandemic, caused by SARS-CoV2, has generated an extremely significant increase in the number of patients admitted to ICUs in recent years since the end of 2019. Objective: To identify the most common microorganisms in ventilator-associated pneumonia in patients with and without Covid and to compare the microorganisms causing ventilator-associated pneumonia in patients with and without Covid. Methodology: This is a retrospective observational study carried out by collecting information from medical records present in the Medical and Statistical Archive Service of Hospital Emílio Carlos and Hospital Padre Albino de Catanduva / SP. The medical records of patients with pulmonary infection due to the use of invasive mechanical ventilatory support from January 2020 to December 2021 will be analyzed, comparing the causative microorganisms in those patients infected and not infected with SARS-CoV-2. Results: Ninety patients who had tracheal aspirate/bronchoalveolar lavage culture were analyzed. Of these, 40 patients had Acinetobacter baumanni identified in the culture, and 24 patients had Klebsiella pneumoniae. The others varied between Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Proteus mirabilis, among other microorganisms. In addition, the most frequent microorganisms in the culture and their relationship with Covid were analyzed, and it was observed that of the 40 patients with Acinetobacter baumanni in culture, 29 had Covid, and of the 24 patients with positive culture for Klebsiella pneumoniae, 14 had Covid. Conclusion: Finally, our work covers an important topic in the hospital setting: pulmonary infections during hospitalization, raising a relevant discussion to prevent and identify microorganisms early in search of a good outcome for the patient.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper